Source link : https://newshealth.biz/health-news/sglt2-inhibitors-can-modulate-adiposopathy-in-ckd/
The use of SGLT2 inhibitors, especially dapagliflozin, can lower adiposopathy parameters in patients with CKD, regardless of diabetes status, a cohort study finds. Medscape News UK Source link : https://www.medscape.com/viewarticle/sglt2-inhibitors-can-modulate-adiposopathy-ckd-2025a100104n?src=rss Author : Publish date : 2025-12-25 12:00:00 Copyright for syndicated content belongs to the linked Source.
The post SGLT2 Inhibitors Can Modulate Adiposopathy in CKD first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-25 12:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8